Altogether these findings indicate a novel role for AR and ER signaling in AR+/ER+ breast cancer compared to the role of AR in TNBC or ER in AR-low/ER+ breast cancer models in response to radiation treatment with important clinical implications for this subset of patients. This evidence concerns the gene AR and breast cancer.